ImmunityBio Inc. (NASDAQ: IBRX) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C. April 17, 2026 · Financial Post Contact Read MoreVisit newsbetsport.bond for more information. Read full story at source